CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
153 hedge funds and large institutions have $220M invested in Clovis Oncology, Inc. in 2020 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 39 increasing their positions, 42 reducing their positions, and 31 closing their positions.
Holders
153
Holders Change
+6
Holders Change %
+4.08%
% of All Funds
3.38%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
41
Increased
39
Reduced
42
Closed
31
Calls
$61.7M
Puts
$29.6M
Net Calls
+$32M
Net Calls Change
+$35.7M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$8.53M |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$6.36M |
| 3 |
3
SG Americas Securities
New York
|
$3.81M |
| 4 |
CAC
4
Cowen and Company
New York
|
$2.96M |
| 5 |
IC
5
Ikarian Capital
Dallas,
Texas
|
$2.62M |
